kabutan

Pharma Foods, First Half Ordinary Profit Decreases by 58%, Nov-Jan Ordinary Profit Turns to Loss

Wed Mar 12, 2025 1:30 pm JST Earnings

2929 Pharma Foods International Co., Ltd. 【J-GAAP】

Earnings Report

Pharma Foods International Co., Ltd. <2929> [TSE Prime] announced its financial results in the afternoon session on March 12th (13:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending July 2025 (August 2024 to January 2025) significantly dropped 58.2% from the same period last year to 0.64 billion yen. The progress rate toward the full-year plan of 2.3 billion yen was 28.0%, almost the same as the same period of the previous year of 29.4%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the February to July period (2H) is expected to significant drop 55.4% from the same period last year to 1.65 billion yen.

In the most recent three-month period, from November to January (2Q), the consolidated ordinary profit/loss turned to a loss of 0.24 billion yen (compared to a profit of 0.93 billion yen in the same period last year). The operating profit/loss margin drastically worsened from 6.0% in the same period last year to -1.7%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Aug - Jan, 2022 35,143 -883 -912 -914 -31.6 ー Mar 7, 2023 J-GAAP
Aug - Jan, 2023 31,652 1,535 1,542 768 26.7 29.4 Mar 11, 2024 J-GAAP
Aug - Jan, 2024 29,857 623 645 229 8.1 28.0 Mar 12, 2025 J-GAAP
YoY -5.7% -59.4% -58.2% -70.2% -69.8%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug - Jan, 2024 Guidance ー ー ー ー － 12.50 Sep 12, 2024 J-GAAP
Aug - Jan, 2024 Results 29,857 623 645 229 8.1 12.50 Mar 12, 2025 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Feb - Jul, 2024 30,495 3,578 3,707 2,437 85.7 15 Sep 12, 2024 J-GAAP
Feb - Jul, 2025 Guidance 35,143 1,377 1,655 1,371 47.5 12.50 Mar 12, 2025 J-GAAP
YoY +15.2% -61.5% -55.4% -43.7% -44.6%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul, 2023 68,572 3,610 3,540 3,081 106.7 22 Sep 11, 2023 J-GAAP
Jul, 2024 62,147 5,113 5,249 3,205 112.7 25 Sep 12, 2024 J-GAAP
Jul, 2025 Guidance 65,000 2,000 2,300 1,600 55.4 25 Sep 12, 2024 J-GAAP
YoY +4.6% -60.9% -56.2% -50.1% -50.8%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Nov - Jan, 2023 15,510 934 937 482 16.7 6.0 Mar 11, 2024 J-GAAP
Feb - Apr, 2024 15,519 1,731 1,681 1,088 38.1 11.2 Jun 10, 2024 J-GAAP
May - Jul, 2024 14,976 1,847 2,026 1,349 47.4 12.3 Sep 12, 2024 J-GAAP
Aug - Oct, 2024 14,596 882 888 360 12.9 6.0 Dec 11, 2024 J-GAAP
Nov - Jan, 2024 15,261 -259 -243 -131 -4.6 -1.7 Mar 12, 2025 J-GAAP
YoY -1.6% － － － －

Related Articles